ESMO Events 2025

Meetings opens in new tab/window | ESMO opens in new tab/window

Welcome to our ESMO Virtual Congress site where we showcase the very best from ESMO's flagship portfolio.

ESMO Targeted Anticancer Therapies Congress 2025 opens in new tab/window

This multi-stakeholder forum brings together researchers, industry partners, investors, and regulatory bodies under the same roof, making the event essential for any professional involved in the development of new anticancer drugs.

Below a collection of papers recently published in ESMO’s premier journals carefully selected to reflect the themes of the meeting.

Annals of Oncology

• Biomarker analyses from the phase III randomized CLEAR trial: lenvatinib plus pembrolizumab versus sunitinib in advanced renal cell carcinoma opens in new tab/window R.J. Motzer, C. Porta, M. Eto, T.E. Hutson, S.Y. Rha, J.R. Merchan, E. Winquist, H. Gurney, V. Grünwald, S. George, J. Markensohn, J.E. Burgents, R. Cristescu, P. Sachdev, Y. Narita, J. Huang, Z. Zhao, C.E. Okpara, Y. Minoshima, T.K. Choueiri

• A Model for Decoding Resistance in Precision Oncology: Acquired Resistance to FGFR inhibitors in Cholangiocarcinoma opens in new tab/window L. Goyal, D. DiToro, F. Facchinetti, E.E. Martin, P. Peng, I. Baiev, R. Iyer, J. Maurer, S. Reyes, K. Zhang, U. Majeed, J.E. Berchuck, C.T. Chen, C. Walmsley, C. Pinto, D. Vasseur, J.D. Gordan, K. Mody, M. Borad, T. Karasic, N. Damjanov, B.P. Danysh, E. Wehrenberg-Klee, A.R. Kambadakone, S.K. Saha, I.D. Hoffman, K.J. Nelson, S. Iyer, X. Qiang, C. Sun, H. Wang, L. Li, M. Javle, B. Lin, W. Harris, A.X. Zhu, J.M. Cleary, K.T. Flaherty, T. Harris, R.T. Shroff, I. Leshchiner, L. Parida, R.K. Kelley, J. Fan, J.R. Stone, N.V. Uboha, H. Hirai, H. Sootome, F. Wu, D.C. Bensen, A. Hollebecque, L. Friboulet, J.K. Lennerz, G. Getz, D. Juric

ESMO Open

• Nivolumab combination therapies in patients with advanced gastric and gastroesophageal junction cancer: the phase II FRACTION gastric cancer study opens in new tab/window G. Ku, G.M. Haag, H. Park, V.K. Lam, T.J. George, S.S. Kim, M. Gutierrez, V. Shankaran, S. Stein, C.S. Denlinger, E. Elimova, A. Nagrial, A.R. He, M.B. Sawyer, H.H. Yoon, R. Geva, J. Starr, G. Curigliano, T. Golan, R. von Moos, R. Fritsch, D. Lim, Q. Wang, A. Patel, T. Aoyama, M. Lei, D. Greenawalt, M. Di Bartolomeo

• A machine learning-based analysis of nationwide cancer comprehensive genomic profiling data across cancer types to identify features associated with recommendation of genome-matched therapy opens in new tab/window H. Ikushima, K. Watanabe, A. Shinozaki-Ushiku, K. Oda, H. Kage

Immuno-Oncology and Technology

• An adjusted droplet digital PCR assay for quantification of vector copy number in CAR-T cell and TCR-T cell products opens in new tab/window J. Ma, S. Meyer, J. Olweus, C. Jin, D. Yu

ESMO Gastrointestinal Oncology

• A stratified two-stage tumor molecular profiling algorithm to identify clinically actionable molecular alterations in pancreatic cancer☆ opens in new tab/window S. Hussung, D. Akhoundova, C. Pistoni, D. Lenggenhager, A. Töpfer, C. Pauli, B. Pestalozzi, C. Britschgi, M. Zoche, M. Rechsteiner, H. Moch, A. Weber, R. Fritsch

ESMO affiliated journals

• AI-based strategies in breast mass ≤ 2 cm classification with mammography and tomosynthesis opens in new tab/window Zhenzhen Shao, Yuxin Cai, Yujuan Hao, Congyi Hu, Ziling Yu, Yue Shen, Fei Gao, Fandong Zhang, Wenjuan Ma, Qian Zhou, Jingjing Chen, Hong Lu

• Validation of the CTS5 in four prospective, multicenter, randomized ABCSG trials opens in new tab/window Kerstin Wimmer, Dominik Hlauschek, Marija Balic, Georg Pfeiler, Richard Greil, Christian F. Singer, Stefan Halper, Günther Steger, Christoph Suppan, Simon Peter Gampenrieder, Ruth Helfgott, Daniel Egle, Martin Filipits, Raimund Jakesz, Lidija Sölkner, Christian Fesl, Michael Gnant, Florian Fitzal on behalf of the Austrian Breast & Colorectal Cancer Study Group

• Antibody-drug conjugates in NSCLC with actionable genomic alterations: Optimizing smart delivery of chemotherapy to the target opens in new tab/window Giannis Mountzios, Stephanie P.L. Saw, Lizza Hendriks, Jessica Menis, Tina Cascone, Oscar Arrieta, Jarushka Naidoo, Prodromos Koutoukoglou, Massimiliano Cani, Antoine Lefevre, Alfredo Addeo, Solange Peters, Jordi Remon

• Individualizing first-line treatment for advanced urothelial carcinoma: A favorable dilemma for patients and physicians opens in new tab/window Enrique Grande, Syed A. Hussain, Philippe Barthélémy, Ravindran Kanesvaran, Patrizia Giannatempo, David J. Benjamin, Jason Hoffman, Alison Birtle

• Targeted therapy for older patients with an oncogene driven non-small cell lung cancer: Recommendations from a SIOG expert group opens in new tab/window L. Decoster, D.R. Camidge, J.A. Fletcher, A. Addeo, A. Greystoke, K. Kantilal, L. Bigay Game, R. Kanesvaran, F. Gomes

• Blood-brain barrier and blood-brain tumor barrier penetrating peptide-drug conjugate as targeted therapy for the treatment of lung cancer brain metastasis opens in new tab/window Meng-Zhu Zheng, Zhan-Qun Yang, Sun-Li Cai, Li-Ting Zheng, Yuan Xue, Long Chen, Jian Lin

• SOHO State of the Art Updates and Next Questions | CAR T Cells in T Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma opens in new tab/window Daniil Shmidt, Maksim Mamonkin

• Expert Opinion on Multiple Myeloma Treatment in Brazil in the Bispecific Antibody Era opens in new tab/window Vania Hungria, Jorge Vaz Pinto Neto, MD, PhD, Pedro Manoel Marques Garibaldi, Angela Marie Jansen, Roberto Jose Pessoa de Magalhães Filho, Fernando Vieira Pericole, Gayatri Sanku, Angelo Maiolino

ESMO's Journal Portfolio

While diverse in nature and in content, these journals offer ESMO members and the oncology community a highly visible platform to publish important scientific studies, and a highly credible source for educational updates. Elsevier is the proud publisher of Annals of Oncology, Immuno-Oncology and Technology (IOTECH), ESMO Open, ESMO Gastrointestinal Oncology, ESMO Real World Data and Digital Oncology, ESMO Rare Cancers, and ESMO Affiliated Journals The Breast, Lung Cancer, Cancer Treatment Reviews and Clinical Lymphoma Myeloma and Leukemia.